Concepedia

Author

James A. Milligan

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

J Milligan, J. A. MILLIGAN, J. MILLIGAN, J. Milligan, JAMES A. MILLIGAN, James A. Milligan, James Milligan, Shree Agrawal

32

Publications

3.7K

Citations

22

H-Index

56

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)
JA

About

James A. Milligan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

19

2.9K

2

Biochemistry

15

15

981

3

Natural Sciences

8

8

450

4

Health Sciences

1

1

42

5

Allergy

1

1

1.7K

James A. Milligan

×

25

Publications

3.7K

Citations

22

H-Index

YearCitations

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom,

Science

2002

1.7K

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu,

Journal of Pharmacology and Experimental Therapeutics

2004

332

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart,

Science

2017

329

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

Martha Kurtz, George K. Abruzzo, Amy Flattery,

Infection and Immunity

1996

137

Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis

Suzanne Mandala, Rosemary Thornton, Mark Rosenbach,

Journal of Biological Chemistry

1997

137

Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase

Suzanne Mandala, Rosemary Thornton, James A. Milligan,

Journal of Biological Chemistry

1998

119

Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub>

Zhen Li, Weirong Chen, Jeffrey J. Hale,

Journal of Medicinal Chemistry

2005

99

A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists

Jeffrey J. Hale, Christopher L. Lynch, William Neway,

Journal of Medicinal Chemistry

2004

88

Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720

Jeffrey J. Hale, William Neway, Sander G. Mills,

Bioorganic & Medicinal Chemistry Letters

2004

73

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis

Martha Kurtz, Cameron Douglas, J A Marrinan,

Antimicrobial Agents and Chemotherapy

1994

71

Page 1